Annals of surgery
-
The purpose of the current study is to determine the efficacy of a PI3K/mTOR dual inhibitor, LY3023414, on established EAC in an in vivo model. ⋯ LY3023414 demonstrates efficacy against EAC in a preclinical model, establishing the rationale for clinical testing.